2021
DOI: 10.6002/ect.2018.0162
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Polymorphism of HLA-G 14-bp Insertion/Deletion in Pancreas Transplant Recipients and Its Association With Type 1 Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 37 publications
2
6
0
Order By: Relevance
“…Such type of studies has also been carried out in organ‐specific autoimmune diseases. Thus, in type 1 diabetes, the HLA‐G 14 bp INS genotype was reported to be a diabetes risk factor and might, therefore, be involved in the pathogenesis of the disease (Rezaei et al, 2019).…”
Section: Hla‐g and Diseasementioning
confidence: 99%
“…Such type of studies has also been carried out in organ‐specific autoimmune diseases. Thus, in type 1 diabetes, the HLA‐G 14 bp INS genotype was reported to be a diabetes risk factor and might, therefore, be involved in the pathogenesis of the disease (Rezaei et al, 2019).…”
Section: Hla‐g and Diseasementioning
confidence: 99%
“…In the context of the Cusp theory, however, it is important to mention that HLA-G immune modulatory effect has been documented in several autoimmune conditions as well. For example, polymorphisms in the HLA-G gene have been found to be a significant risk factor for type 1 diabetes (128), systemic lupus erythematosus (129,130), RA (131), experimental autoimmune uveitis (132), systemic sclerosis (130), as well as multiple sclerosis and several autoimmune skin conditions (133), asthma (134) and Graves' disease (135), however, it is important to mention that results for associations between HLA-G and diseases are often times contradictory or inconclusive, and warrant further investigation.…”
Section: Immune Modulatory and Autoimmune Disease Effectsmentioning
confidence: 99%
“…As shown in Table 1 , most of the clinical studies showed that tissue or blood expression of HLA-G with any of the above mentioned techniques has a protective role, induction of immune tolerance and subsequent graft acceptance in transplantation. In some studies however, the relation with graft acceptance was not so clear and in these studies expression of HLA-G was determined by time after transplantation ( 96 ), inflammatory processes, or specific genotypes associated with diabetes ( 110 , 123 ) (see Table 1 ). The study by Moroso et al.…”
Section: Transplantationmentioning
confidence: 99%
“…In studies concerning the HLA-G polymorphisms, it has been shown that HLA-G polymorphism can act as a risk factor for diabetes mellitus in both kidney and pancreas transplantation ( 106 , 123 ). Both HLA-G 14bp and +3142G/G show associations with obesity post kidney transplantation ( 92 , 106 ).…”
Section: Transplantationmentioning
confidence: 99%